Soy Intake is Associated with Increased 2-Hydroxylation and Decreased 16α-Hydroxylation of Estrogens in Asian-American Women

Introduction: In Asian and Asian-American women, soy consumption is associated with reduced breast cancer risk, perhaps due to its effects on estrogen production or metabolism. In a sample of Asian-American women, we investigated the associations of usual adult soy intake with the urinary concentrations of 15 estrogens and estrogen metabolites (EM) measured using liquid chromatography-tandem mass spectrometry. Methods: Participants included 430 Chinese-American, Japanese-American, and Filipino-American women, ages 20 to 55 years, and living in San Francisco-Oakland (California), Los Angeles (California), or Oahu (Hawaii). They were postmenopausal (n = 167) or premenopausal in luteal phase (n = 263) when 12-hour urine samples were collected. Robust linear regression was used to assess soy tertiles as predictors of log-transformed EM measures. Individual and grouped EM were considered as concentrations (pmol/mg creatinine) and as percentages of total EM (%EM). Results: Factor analysis confirmed that EM groups defined by metabolic pathways appropriately captured covariation in EM profiles. Total EM concentrations were not significantly associated with soy in premenopausal or postmenopausal women. Among all women, %2-hydroxylated EM and %4-hydroxylation pathway EM were 16% higher (Ptrend = 0.02) and 19% higher (Ptrend = 0.03) in the highest versus lowest soy tertiles, respectively. In contrast, 16% hydroxylated EM were 11% lower (Ptrend < 0.01). Results were consistent across ethnic and menopausal groups and after adjustment for westernization measured by birthplace (Asia or United States). Discussion: Findings suggest that regular soy intake is associated with increased ratios of 2:16-pathway EM and with higher relative levels of 4-hydroxylated EM. The observed variations in estrogen metabolism might modify breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2009;18(10):2751–60)

[1]  C. Nagata,et al.  Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. , 1997, Nutrition and cancer.

[2]  A. Conney,et al.  Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? , 1998, Cancer research.

[3]  A. Conney,et al.  Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. , 2003, Endocrinology.

[4]  A M Nomura,et al.  Migration patterns and breast cancer risk in Asian-American women. , 1993, Journal of the National Cancer Institute.

[5]  S. Kardia,et al.  CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. , 2006, The American journal of medicine.

[6]  A. Wu,et al.  Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  B. Trock,et al.  Meta-analysis of soy intake and breast cancer risk. , 2006, Journal of the National Cancer Institute.

[8]  J. C. Barrett,et al.  Effects of a catechol‐O‐methyltransferase inhibitor on catechol estrogen‐induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells , 2007, International journal of cancer.

[9]  R. Weinshilboum,et al.  Estrogen metabolism by conjugation. , 2000, Journal of the National Cancer Institute. Monographs.

[10]  M. Kurzer,et al.  Dietary phytoestrogens. , 1997, Annual review of nutrition.

[11]  M. Kibriya,et al.  Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer , 2007, Breast Cancer Research and Treatment.

[12]  G. Anderson,et al.  Drug Interaction Potential of Soy Extract and Panax Ginseng , 2003, Journal of clinical pharmacology.

[13]  Ling Jiang,et al.  Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells. , 2007, Carcinogenesis.

[14]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[15]  A M Nomura,et al.  Tofu and risk of breast cancer in Asian-Americans. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Jennifer D. Brooks,et al.  Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. , 2004, The American journal of clinical nutrition.

[17]  J. Yager,et al.  Tissue-specific synthesis and oxidative metabolism of estrogens. , 2000, Journal of the National Cancer Institute. Monographs.

[18]  K. Anderson,et al.  Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. , 2000, Cancer research.

[19]  M. Pike,et al.  Childhood Soy Intake and Breast Cancer Risk in Asian American Women , 2009, Cancer Epidemiology Biomarkers & Prevention.

[20]  M. Martini,et al.  Effects of soy intake on sex hormone metabolism in premenopausal women. , 1999, Nutrition and cancer.

[21]  J. Weisz,et al.  Biogenesis and inactivation of catecholestrogens. , 1998, Advances in pharmacology.

[22]  D. N. Kirk,et al.  Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. , 1984, The American journal of clinical nutrition.

[23]  G. Maskarinec,et al.  Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  T. Veenstra,et al.  A liquid chromatography–mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites , 2007, Nature Protocols.

[25]  M. Ritchie,et al.  Estrogens, Enzyme Variants, and Breast Cancer: A Risk Model , 2006, Cancer Epidemiology Biomarkers & Prevention.

[26]  W. Koh,et al.  Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. , 2005, Carcinogenesis.

[27]  H. Adlercreutz,et al.  The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption. , 2005, The Journal of nutrition.

[28]  J. Yager,et al.  Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. , 2002, Pharmacogenetics.

[29]  M. Pike,et al.  Epidemiology of soy exposures and breast cancer risk , 2008, British Journal of Cancer.

[30]  J. Potter,et al.  Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  T. Fears,et al.  A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  N. Vaziri,et al.  Colorimetric rate method for the determination of creatinine as implemented by the Beckman Creatinine Analyzer 2. , 1980, The American journal of medical technology.

[33]  M. van den Berg,et al.  Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  R. Weinshilboum,et al.  Chapter 6: Estrogen Metabolism by Conjugation , 2000 .

[35]  K. Anderson,et al.  Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. , 2000, Cancer research.

[36]  G. Maskarinec,et al.  Urinary Sex Steroid Excretion Levels During a Soy Intervention Among Young Girls: A Pilot Study , 2005, Nutrition and cancer.

[37]  M. Pike,et al.  A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. , 2005, The American journal of clinical nutrition.

[38]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[39]  M. Pike,et al.  Effects of soy foods on ovarian function in premenopausal women , 2000, British Journal of Cancer.

[40]  B. Pittman,et al.  Soy isoflavone intake and estrogen excretion patterns in young women: effect of probiotic administration. , 2007, In vivo.

[41]  P. Muti,et al.  Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. , 2006, Biochimica et biophysica acta.

[42]  K. Setchell,et al.  Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. , 1994, The American journal of clinical nutrition.

[43]  T. Key,et al.  Soy Milk Intake and Plasma Sex Hormones: A Cross-Sectional Study in Pre- and Postmenopausal Women (EPIC-Oxford) , 2001, Nutrition and cancer.

[44]  A. Duncan,et al.  Menstrual cycle effects on urinary estrogen metabolites. , 1999, The Journal of clinical endocrinology and metabolism.

[45]  T. Key Hormones and cancer in humans. , 1995, Mutation research.

[46]  S. Leone‐Kabler,et al.  Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  S. Crawford,et al.  Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women. , 2006, The Journal of nutrition.

[48]  A. Duncan,et al.  Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[49]  M. Murray Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. , 2006, Current drug metabolism.

[50]  M. McCarty Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. , 2006, Medical hypotheses.

[51]  A. Duncan,et al.  Soy consumption alters endogenous estrogen metabolism in postmenopausal women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[52]  A. Wu,et al.  Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. , 2003, Carcinogenesis.

[53]  L. Kolonel,et al.  Soy intake is related to a lower body mass index in adult women , 2008, European journal of nutrition.

[54]  K. Korzekwa,et al.  Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. , 1997, Carcinogenesis.

[55]  M. Pike,et al.  Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. , 2002, Carcinogenesis.

[56]  H. Bradlow,et al.  16α‐Hydroxylation of Estradiol: A Possible Risk Marker for Breast Cancer , 1986 .